Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

CSE/NURL stock hub

CSE/NURL has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/NURLis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.5M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/NURL

In the news

Latest news · CSE/NURL

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-1,179.2

P25 n/aP50 n/aP75 n/a

ROIC-64

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/NURL market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

117

Groups with data

Currency

CAD

Showing 117 of 117 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 3.3M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	CAD 2.5M
Price	CAD 0.02
Price currency	CAD
Sic	2836
Symbol	cse/NURL
Website	https://www.neuraltherapeutics.ca

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-49.83%
EV Earnings	-2.59x
P/B ratio	3.89x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	CAD -1.3M
ROA	-50.56
ROCE	-61.03
ROE	-1,179.2
ROIC	-64.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-57.17%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	CAD 1.6M
Cash	CAD 62,791
Current Assets	CAD 71,912
Current Liabilities	CAD 183,438
Debt	CAD 804,670
Debt Equity	CAD 1.23
Equity	CAD 653,224
Liabilities	CAD 988,108
Long Term Assets	CAD 1.6M
Long Term Liabilities	CAD 804,670
Net Cash	CAD -741,879
Net Cash By Market Cap	CAD -29.23
Net Debt Equity	CAD 1.14
Tangible Book Value	CAD 653,224
Tangible Book Value Per Share	CAD 0

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.39
Net Working Capital	CAD -174,317
Quick ratio	0.38
Working Capital	CAD -111,526

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-87.15%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-57.14%
200-day SMA	0.02
50-day SMA	0.02
50-day SMA vs 200-day SMA	50under200
All Time High	0.05
All Time High Change	-70%
All Time High Date	2025-04-23
All Time Low	0.01
All Time Low Change	50%
All Time Low Date	2025-09-25
ATR	0
Beta1y	-0.84
Beta2y	0.01
Ch YTD	-25
High	0.02
High52	0.04
High52 Date	2025-05-28
High52ch	-62.5%
Low	0.01
Low52	0.01
Low52 Date	2026-05-06
Low52ch	50%
Ma50ch	-1.32%
Price vs 200-day SMA	-29.91%
RSI	49.78
RSI Monthly	42.86
RSI Weekly	47.1
Sharpe ratio	1.12x
Sortino ratio	2
Total Return	-87.15%
Tr YTD	-25
Tr1m	50%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD -889,801

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	167,650,415%
Net Borrowing	-13,198
Shares Insiders	0.92%
Shares Institutions	7.14%
Shares Out	169,200,537
Shares Qo Q	0%
Shares Yo Y	87.15%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	26,150.7x
Bv Per Share	0
Ch1m	50
Ch1y	-57.14
Ch6m	-25
Change	0%
Change From Open	0
Close	0.02
Days Gap	0
Dollar Volume	265.5
Earnings Date	2026-06-25
EBIT	CAD -889,801
EPS	CAD -0.01
F Score	1
Financing CF	-47,806
Fiscal Year End	July
Founded	2,020
Is Primary Listing	1
Last Earnings Date	2025-11-21
Last Report Date	2026-01-31
Ma150	0.02
Ma150ch	-17.58%
Ma20	0.01
Ma20ch	4.9%
Net CF	-457,277
Next Earnings Date	2026-06-25
Open	0.02
Position In Range	100
Price Date	2026-05-06
Ptbv Ratio	3.89
Relative Volume	0.68x
Share Based Comp	409,044
Tr6m	-25%
Volume	17,700

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/NURL pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/NURL stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/NURL?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.1%

Share of float held by funds and institutions

Insider ownership

+0.9%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+87.1%

Negative means the company is buying back shares.

Technical

CSE/NURL momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

49.8

Neutral momentum band

Price vs 200-day MA

-29.9%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

1.12

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/NURL

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/NURL stock rating?

cse/NURL is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/NURL analysis?

The full report lives at /stocks/cse/NURL/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/NURL?

The latest report frames cse/NURL around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/NURL page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.